Tirzepatide: unveiling a New Dawn in Dual-Targeted diabetes and obesity management

Introduction Incretin-based therapies have emerged as effective treatments for type 2 diabetes (T2D) and obesity. However, not all patients achieve optimal outcomes with existing treatments, highlighting the need for more effective solutions.